Research ArticleANTIBODIES

Enhancing FcγR-mediated antibody effector function during persistent viral infection

See allHide authors and affiliations

Science Immunology  21 Sep 2018:
Vol. 3, Issue 27, eaao3125
DOI: 10.1126/sciimmunol.aao3125

Article Information

vol. 3 no. 27

Published By: 
  • Received July 6, 2017
  • Revision received May 28, 2018
  • Accepted August 1, 2018
  • .

Author Information

  1. Andreas Wieland1,*,
  2. Alice O. Kamphorst1,,
  3. Rajesh M. Valanparambil1,
  4. Jin-Hwan Han1,,
  5. Xiaojin Xu1,
  6. Biswa P. Choudhury2 and
  7. Rafi Ahmed1,*
  1. 1Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
  2. 2Glycotechnology Core Resources, University of California at San Diego, La Jolla, CA 92093, USA.
  1. *Corresponding author. Email: awielan{at} (A.W.); rahmed{at} (R.A.)
  • Present address: Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

  • Present address: Merck Research Laboratories, Palo Alto, CA 94304, USA.


Article usage

Article usage:

No statistics are available.

Stay Connected to Science Immunology

Navigate This Article